196 related articles for article (PubMed ID: 32916316)
1. iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research.
Chen X; Guo Y; Chen X
Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):150-160. PubMed ID: 32916316
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant cancer biomarkers and pharmacogenetic assays.
Patel JN; Mandock K; McLeod HL
J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
5. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
6. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
7. [Applied pharmacogenetic].
Thervet É
Nephrol Ther; 2016 Apr; 12 Suppl 1():S99-S103. PubMed ID: 26972091
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
Trends Pharmacol Sci; 2001 Aug; 22(8):420-6. PubMed ID: 11479005
[TBL] [Abstract][Full Text] [Related]
9. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
van Schaik RH
Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
11. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
Soh TI; Yong WP
Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
[TBL] [Abstract][Full Text] [Related]
12. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.
Lee SY; McLeod HL
J Pathol; 2011 Jan; 223(1):15-27. PubMed ID: 20818641
[TBL] [Abstract][Full Text] [Related]
15. Infusion of pharmacogenetics into cancer care.
Prows CA
Semin Oncol Nurs; 2011 Feb; 27(1):45-53. PubMed ID: 21255712
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of cancer drugs.
Hertz DL; Rae J
Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and personalised medicine: maintain a critical approach.
Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
[TBL] [Abstract][Full Text] [Related]
18. Personalised medicine for cancer: from drug development into clinical practice.
Jain KK
Expert Opin Pharmacother; 2005 Aug; 6(9):1463-76. PubMed ID: 16086635
[TBL] [Abstract][Full Text] [Related]
19. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
Donnelly JG
Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]